When was Zoetis founded?

Zoetis was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Zoetis located?

Zoetis is headquartered in Parsippany, United States. It is registered at 31, 3RD FLOOR, KALPATARU SYNERGY OPP. : GRAND HYATT,SANTACRUZ(E), Mumbai City, MUMBAI, Maharashtra, India, 400055.

How many employees does Zoetis have?

As of Jul 31, 2026, the latest employee count at Zoetis is 13518.

Is Zoetis a funded company?

Zoetis is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Apr 01, 2015.

When was the latest funding round of Zoetis?

Zoetis' latest funding was a $***** Grant (prize money) round on Mar 01, 2023, with participation from 1 investor. Its primary sector is Veterinary HealthTech. In United States, the Veterinary HealthTech sector has seen $125M in funding in 2026 to date.

What is the annual revenue of Zoetis?

Annual revenue of Zoetis is more than $1B as on Dec 31, 2025

Where does Zoetis rank among its competitors?

Zoetis ranks 2nd amongst 242 active competitors, of which 31 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Rejuvenate Bio, which secured $19.5M in Jun, 2026.

Who are the top competitors of Zoetis?

Zoetis' top competitors include Ceva, Rejuvenate Bio and Zenex Animal Health. Among them, Rejuvenate Bio secured the most recent funding round in June, 2026.

Zoetis - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Global animal health company dedicated to nurturing the world through animal care. It focuses on advancing animal well-being through a comprehensive approach encompassing medicines, vaccines, diagnostics, and technologies. Driven by science and a passion for animals, the company develops solutions to predict, prevent, detect, and treat diseases in both companion animals and livestock. The company is committed to sustainability and supporting the human-animal bond, particularly by aiding veterinarians. It strives to be a trusted partner in animal health, shaping the future of animal care through innovation and a purpose-driven approach. The company's portfolio includes a range of products for pets, equine, and livestock, supported by research and development, manufacturing, and customer care.

Website: www.zoetis.com/
Social
Email ID: *****@zoetis.com
Phone Number: +1 **********
Registered Address: 31, 3RD FLOOR, KALPATARU SYNERGY OPP. : GRAND HYATT,SANTACRUZ(E), Mumbai City, MUMBAI, Maharashtra, India, 400055

Key Metrics

Founded Year

2013

Location

Parsippany, United States

Stage

Public

Latest Funding Round

Grant (prize money), Mar 01, 2023, $*****

Investors

Gates & 1 more

Ranked

2^nd among 242 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

13,518 as on Jul 31, 2026

Investment & Acquisitions

Vitalrads & 22 more

Similar Companies

Ceva & 212 more

Exit Details

Public

View Zoetis' full profile

Zoetis is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Zoetis India Limited CIN: U46497MH2007PLC203686 , India, Active	Sep 06, 2007	₹100 - ₹500 Cr (As on Mar 31, 2025)	125 (As on Mar 01, 2026)
ZOETIS B.V. CIN: 28813364188 , Croatia, Active	Jul 24, 2012	$0 - $1M (As on Nov 30, 2019)	-
Zoetis Services Llc CIN: 20171050177 , United States, Active	Jan 23, 2017	-	-	-
ZOLA ASPHALT COMPANY LIMITED CIN: 0705542000359 , Thailand, Active	Jul 07, 1999	-	-
ZOETIS PHARMACEUTICAL RESEARCH PRIVATE LIMITED CIN: U24117MH1995FTC084206 , India, Active	Jan 02, 1995	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	56 (As on May 01, 2026)
ZOETIS INC. CIN: 1555280 , United States, Active	Jul 24, 2012	$1B+ (As on Dec 31, 2025)	2 (As on Apr 30, 2022)	-

Zoetis got listed on Feb 01, 2013.

Click here to take a look at Zoetis's IPO in detail

Zoetis has raised funding over 9 rounds. Its first funding round was on Apr 01, 2015. Its latest funding round was a Grant (prize money) round on Mar 01, 2023 for $*****. 1 investor participated in its latest round. Zoetis has 2 institutional investors.

Here is the list of recent funding rounds of Zoetis:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 01, 2023	9387292	Grant (prize money)	9455994	7478349	2116655	6401439
Jan 01, 2023	6914089	Grant (prize money)	4152583	7396694	8912089	Europa
May 01, 2022	5515666	Grant (prize money)	5665117	2875519	6708470	2424117

Access funding benchmarks and valuations. Sign up today!

View details of Zoetis's funding rounds and investors

Zoetis' employee count trend

Zoetis has 13,518 employees as of Jul 26. Here is Zoetis's employee count trend over the years:

Uncover Zoetis' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Zoetis include Ceva, Rejuvenate Bio and Zenex Animal Health. Here is the list of Top 10 competitors of Zoetis, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Ceva 1999, Libourne (France), Acquired	Global animal health company providing innovative solutions for diverse animal species	$214M	Temasek, Sagard & 26 others	76/100
2nd	Zoetis 2013, Parsippany (United States), Public	Global animal health company dedicated to nurturing the world through animal care	-	Gates, Europa	73/100
3rd	Rejuvenate Bio 2018, San Diego (United States), Series A	Developer of gene therapies for treating chronic and age-related diseases	$34M	VCapital, Digitalis Ventures & 12 others	62/100
4th	Zenex Animal Health 2021, Ahmedabad (India), Seed	Manufacturer of veterinary drugs	$60.6K	SBI, Multiples Alternate Asset Management ... & 8 others	57/100
5th	Phage Lab 2010, Macul (Chile), Series A	Developer of bacteriophage treatments for animals	$41M	Collab Fund, Kaszek & 6 others	54/100
6th	Bio-Sourcing 2014, Liege (Belgium), Series A	Manufacturer and supplier of bio-pharmaceuticals for animals	$17.4M	Equitis, Europa & 4 others	54/100
7th	Aquilón Cyl 2012, Leon (Spain), Acquired	Develops and markets products to enhance animal productivity	$3.79M	Clave, EIC Fund & 1 others	52/100
8th	KindredBio 2012, Burlingame (United States), Acquired	Veterinary biotechnology company	$6.9M	EcoR1, SLR Investment Corp	50/100
9th	Astra 2019, Villigen (Switzerland), Seed	Developer of small molecule anti-parasitic drugs using structural data	$9.77M	Digitalis Ventures, MIG Fonds & 3 others	49/100
10th	Adbiotech 2000, Chuncheon si (South Korea), Public	Developer of pharmaceutical products for animal health	-	Magna, ID Ventures & 1 others	47/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Zoetis's competitors? Click here to see the top ones

Zoetis has made 3 investments in companies including Techcyte and Techcyte. Zoetis has also acquired 20 companies including Vitalrads and The Veterinary Pathology Group.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jul 14, 2026	Acquisition	Vitalrads	2010	Cypress (United States)
Apr 30, 2026	Investments	Techcyte	2014	Orem (United States)
Nov 11, 2025	Acquisition	The Veterinary Pathology Group	2001	United Kingdom